Abbott Initiates Study to Evaluate Ablation as a Frontline Treatment for Patient's Suffering from a Common but Complex Cardiac Arrhythmia
LESS-VT Study is the first U.S. clinical trial to evaluate the safety and effectiveness of ablation treatment for patients with monomorphic ventricular tachycardia, a common heart rhythm disorder
Source: Abbott.com - Category: Pharmaceuticals Source Type: news
More News: Arrhythmia | Cardiac Arrhythmia | Cardiology | Clinical Trials | Heart | Pharmaceuticals | Study | Ventricular Tachycardia